RecallDepth
Class I Terminated

Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
April 12, 2022
Posted
May 4, 2022
Recall Number
D-0845-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
89,665 vials
Firm Location
Morgantown, WV, United States

Reason for Recall

Labeling: Missing label on the vial

Distribution

USA nationwide.

Lot / Code Info

Lot #: BF21002800, Exp 8/2023

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class I Drug recalls